As of May 25, 2025, BG Medicine Inc (BGMD) reports a Gross Margin of 67.75%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of BG Medicine Inc's Gross Margin
Over recent years, BG Medicine Inc's Gross Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2015-12-31 | 67.75% |
| 2014-12-31 | 65.70% |
| 2013-12-31 | 65.90% |
| 2012-12-31 | 66.00% |
| 2011-12-31 | 62.12% |
This slight upward trend highlights how BG Medicine Inc manages its operational efficiency and pricing power over time.
Comparing BG Medicine Inc's Gross Margin to Peers
To better understand BG Medicine Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| BG Medicine Inc (BGMD) | 67.75% |
| Sona Nanotech Inc (SONA.CN) | 7775.20% |
| PerkinElmer Inc (PKI) | 6008.00% |
| Quick-Med Technologies Inc (QMDT) | 97.31% |
| Berkeley Lights Inc (BLI) | 68.43% |
| 10X Genomics Inc (TXG) | 67.91% |
Compared to its competitors, BG Medicine Inc's Gross Margin is among the highest compared to peers, indicating superior product pricing power or cost efficiency in production.